N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Not applicable ClinicalTrials.gov

Improving Uroflowmetry Interpretability: Evaluating the Impact of Patient Reminder Systems

Sponsor: Ohio State University • ClinicalTrials.gov ID: NCT07692789

Registry updated: 2026-09-24
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

The purpose of this study is to evaluate the impact of pre-procedure patient reminder systems on patient satisfaction, preparedness, and anxiety among patients undergoing urodynamics studies. The rate of successful procedure completion will be compared between a prospective intervention group and a historical control group to determine whether the intervention improves procedural success and healthcare delivery.

Interventions

  • Patient reminder system (Other)
    Using patient reminder systems before scheduled urodynamics studies on patient satisfaction, preparedness, anxiety, and successful completion of the procedure to improve healthcare delivery by comparing a prospective intervention group with a historical control group.

Eligibility criteria

Inclusion Criteria 1. Age 18 years or older 2. Sex assigned at birth: Female. 3. English-speaking 4. Scheduled to undergo a urodynamics study at the OSU Upper Arlington Outpatient Clinic, OSU New Albany Outpatient Clinic, or OSU Eye and Ear Institute 5. Ability to access a telephone 6. Active MyChart account 7. Ability to provide informed consent 8. Documented post-residual volume of less than 150 mL 9. Ability to be reached by telephone after three call attempts 10. Negative point-of-care urinary tract infection on the day of the scheduled procedure (SOC) Exclusion criteria: 1. Under 18 years of age 2. Patients with structural causes of urinary retention/incomplete bladder emptying (defined as a post-void residual \>150ml) or a positive point-of-care urinary tract infection on the day of the procedure. 3. Men are excluded as the population of interest is the female urogynecology population in both urology and obstetrics and gynecology. 4. Patients without access to a telephone or an active MyChart account are excluded because the intervention relies on telephone calls and electronic messaging for delivery of pre-procedure education and reminders. 5. Individuals who cannot be reached by telephone are excluded because they cannot receive the intervention. 6. Non-English speaking individuals are excluded because they will not be able to receive the standardized phone call in English and will not be able to complete the informed consent.

Conditions

Pelvic Organ Prolapse Urinary Incontinence

Locations

  • Ohio State University Wexner Medical Center — Columbus, Ohio, United States
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record